Myomo (MYO) Shares Outstanding (Weighted Average) (2016 - 2025)
Myomo filings provide 10 years of Shares Outstanding (Weighted Average) readings, the most recent being $42.2 million for Q3 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 12.87% to $42.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $42.2 million, a 12.87% increase, with the full-year FY2024 number at $7.7 million, down 73.8% from a year prior.
- Shares Outstanding (Weighted Average) hit $42.2 million in Q3 2025 for Myomo, up from $41.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $42.2 million in Q3 2025 to a low of $118696.0 in Q1 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $7.1 million (2022), compared with a mean of $17.3 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): surged 5717.35% in 2022 and later tumbled 90.03% in 2023.
- Myomo's Shares Outstanding (Weighted Average) stood at $693643.0 in 2021, then decreased by 1.91% to $680363.0 in 2022, then skyrocketed by 4235.82% to $29.5 million in 2023, then plummeted by 73.8% to $7.7 million in 2024, then skyrocketed by 445.53% to $42.2 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $42.2 million (Q3 2025), $41.5 million (Q2 2025), and $41.5 million (Q1 2025) per Business Quant data.